Implanet (France) Today
| ALIMP Stock | EUR 0.11 0.01 8.33% |
PerformanceWeak
| Odds Of DistressQuite High
|
Implanet is selling at 0.11 as of the 18th of March 2025; that is 8.33% down since the beginning of the trading day. The stock's last reported lowest price was 0.1. Implanet has more than 68 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 18th of December 2024 and ending today, the 18th of March 2025. Click here to learn more.
Implanet S.A. provides various spine, knee, and arthroscopy orthopedic implants in France, the United States, Brazil, and internationally. Implanet S.A. was founded in 2006 and is based in Martillac, France. IMPLANET operates under Medical Devices classification in France and is traded on Paris Stock Exchange. The company has 31.16 M outstanding shares. More on Implanet SA
Moving against Implanet Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Implanet Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Implanet's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Implanet or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and Director | Ludovic Lastennet |
| Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
Implanet SA (ALIMP) is traded on Euronext Paris in France and employs 39 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Implanet's market, we take the total number of its shares issued and multiply it by Implanet's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Implanet SA operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 31.16 M outstanding shares.
Implanet SA has accumulated about 400 K in cash with (3.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Implanet Probability Of Bankruptcy
Ownership AllocationImplanet SA has a total of 31.16 Million outstanding shares. Roughly 99.98 (percent) of Implanet outstanding shares are held by general public with 0.018 % owned by insiders and only 0.0 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Implanet Ownership Details
Implanet SA Risk Profiles
Although Implanet's alpha and beta are two of the key measurements used to evaluate Implanet's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.97 | |||
| Standard Deviation | 5.07 | |||
| Variance | 25.72 | |||
| Risk Adjusted Performance | 0.0074 |
Implanet Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Implanet without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Implanet Corporate Management
Elected by the shareholders, the Implanet's board of directors comprises two types of representatives: Implanet inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Implanet. The board's role is to monitor Implanet's management team and ensure that shareholders' interests are well served. Implanet's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Implanet's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David Dieumegard | VP Financial | Profile | |
| Rgis Coudic | RD Director | Profile | |
| Georges Legallois | Marketing Mang | Profile | |
| Yvanna Peigne | Operations Mang | Profile |
Additional Tools for Implanet Stock Analysis
When running Implanet's price analysis, check to measure Implanet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implanet is operating at the current time. Most of Implanet's value examination focuses on studying past and present price action to predict the probability of Implanet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implanet's price. Additionally, you may evaluate how the addition of Implanet to your portfolios can decrease your overall portfolio volatility.